3 hours Leerink Partnrs Research Analysts Cut Earnings Estimates for Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)MarketBeat
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) – Equities research analysts at Leerink Partnrs reduced their Q3 2024 earnings per share estimates for Alnylam Pharmaceuticals in a research report issued on Monday, October 14th. Leerink Par…
Earnings · Nasdaq 100 · Pharmaceuticals · Science
X